首页> 美国卫生研究院文献>Science Advances >The ferroportin Q248H mutation protects from anemia but not malaria or bacteremia
【2h】

The ferroportin Q248H mutation protects from anemia but not malaria or bacteremia

机译:铁转运蛋白Q248H突变可预防贫血但不能预防疟疾或菌血症

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Iron acquisition is critical for life. Ferroportin (FPN) exports iron from mature erythrocytes, and deletion of the Fpn gene results in hemolytic anemia and increased fatality in malaria-infected mice. The FPN Q248H mutation (glutamine to histidine at position 248) renders FPN partially resistant to hepcidin-induced degradation and was associated with protection from malaria in human studies of limited size. Using data from cohorts including over 18,000 African children, we show that the Q248H mutation is associated with modest protection against anemia, hemolysis, and iron deficiency, but we found little evidence of protection against severe malaria or bacteremia. We additionally observed no excess Plasmodium growth in Q248H erythrocytes ex vivo, nor evidence of selection driven by malaria exposure, suggesting that the Q248H mutation does not protect from malaria and is unlikely to deprive malaria parasites of iron essential for their growth.
机译:铁的获取对于生命至关重要。 Ferroportin(FPN)从成熟的红细胞中输出铁,Fpn基因的缺失会导致溶血性贫血和疟疾感染小鼠的死亡增加。 FPN Q248H突变(在248位的谷氨酰胺转变为组氨酸)使FPN对铁调素诱导的降解具有部分抵抗力,并且在人类规模有限的研究中与疟疾的预防相关。使用包括18,000多个非洲儿童在内的队列数据,我们显示Q248H突变与适度的抗贫血,溶血和铁缺乏症相关,但我们没有发现针对严重疟疾或菌血症的保护证据。我们还观察到离体Q248H红细胞中没有疟原虫的过量生长,也没有疟疾暴露驱动的选择证据,这表明Q248H突变不能防止疟疾,并且不可能剥夺疟疾寄生虫对其生长必不可少的铁。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号